Back to notes
How does non-adherence to oral medications impact patients with chronic illnesses like schizophrenia?
Press to flip
Non-adherence can lead to relapse and have irreversible effects on the brain, which may affect the antipsychotic response.
In what way are LAIs considered one of the most effective tools in psychiatry?
Learning how to use them effectively and conducting productive conversations with patients makes LAIs a powerful tool.
What should clinicians know about LAIs to optimize patient outcomes?
Clinicians should understand the variety of LAIs, their initiation and loading regimens, and maintain open communication with patients.
What are the different frequency options available for LAIs?
LAIs range in frequency from every two weeks to every six months.
Why are LAIs particularly important in early intervention for schizophrenia?
Using LAIs early after diagnosis can maximize benefits and minimize risks, including irreversible effects on the brain due to non-adherence.
What is one of the main benefits of Long-Acting Injectable Antipsychotics (LAIs) in the context of schizophrenia?
LAIs help reduce the risk of relapse substantially in patients with schizophrenia.
How does patient preference influence the use of LAIs?
Patient preference plays a significant role in determining the frequency and type of injection (IM vs. subcutaneous).
Why might LAIs not entirely prevent hospital readmissions in schizophrenia patients?
While LAIs reduce the risk of relapse, they do not completely eliminate it.
In terms of effectiveness, how do LAIs compare to oral antipsychotics?
LAIs are not necessarily more effective in symptom reduction if there is 100% adherence to oral medications, but they ensure better adherence usually.
What is a practical approach for clinicians to introduce LAIs to hesitant patients?
Suggesting a trial period where patients can switch back to oral medications if they find LAIs unsatisfactory.
Why is it important to have ongoing discussions with patients about LAIs?
Continuous dialogue ensures that patient concerns and fears are addressed, and it helps in making shared decisions about treatment.
What are some other chronic conditions with similar non-adherence rates to schizophrenia?
Bipolar disorder, major depressive disorder, anxiety, diabetes, hypertension, and asthma.
How does the injection method (IM vs. subcutaneous) influence the choice of LAIs?
Patient preference and the specific needs of the patient can determine whether an intramuscular or subcutaneous method is used.
What role does shared goals play in conversations around LAIs?
Shared goals help in addressing patient concerns and fears while making informed decisions on long-term treatments.
What is a significant consequence of non-adherence to antipsychotic medications?
Non-adherence can lead to irreversible brain changes that affect antipsychotic response.
Previous
Next